Press release -

New and user-friendly probiotic capsule for improved women’s health

Chr. Hansen is on the market with the first oral probiotic capsule for restoration and maintenance of a healthy vaginal flora.

Chr. Hansen’s probiotic capsules for improved urogenital health contains the patented strains GR-1® and RC-14® The products have all been tested in a vast number of clinical studies in several countries.

The capsule format offers women a convenient once a day solution, and the oral dosage is unique and perceived as very user-friendly by end users.

Restoring the bacterial balance

”We are very happy to be on the market with our well-documented probiotic capsule, which I am sure will answer the needs of many women all over the world. Imbalances in the micro flora of the genital area can lead to a number of unpleasant conditions such as bacterial vaginosis (BV). Chr. Hansen’s probiotics can restore the bacterial balance in the vagina and have a very beneficial effect on BV,” says Tine Westerdahl, Head of Marketing, Human Health & Nutrition, Chr. Hansen.

GR-1® and RC-14® is among the best-documented strains for women. The strains have been extensively tested and documented over the last 20 years by Dr. Gregor Reid and Dr. Andrew Bruce from Urex Biotech.

Topics

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S

Boege Allé 10-12
DK-2970 Hoersholm
Denmark

Chr. Hansen website
Investor Relations
Read more about Chr. Hansen
Enter your email address to follow Chr. Hansen Holding A/S

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Chr. Hansen Holding A/S.

Okay